121 related articles for article (PubMed ID: 10862632)
1. Capillary/myocyte mismatch in the heart in renal failure--a role for erythropoietin?
Amann K; Buzello M; Simonaviciene A; Miltenberger-Miltenyi G; Koch A; Nabokov A; Gross ML; Gless B; Mall G; Ritz E
Nephrol Dial Transplant; 2000 Jul; 15(7):964-9. PubMed ID: 10862632
[TBL] [Abstract][Full Text] [Related]
2. Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure.
Amann K; Törnig J; Buzello M; Kuhlmann A; Gross ML; Adamczak M; Buzello M; Ritz E
Kidney Int; 2002 Sep; 62(3):877-84. PubMed ID: 12164869
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function.
Gut N; Piecha G; Aldebssi F; Schaefer S; Bekeredjian R; Schirmacher P; Ritz E; Gross-Weissmann ML
Am J Nephrol; 2013; 38(2):124-35. PubMed ID: 23920063
[TBL] [Abstract][Full Text] [Related]
4. Rats with moderate renal failure show capillary deficit in heart but not skeletal muscle.
Amann K; Neimeier KA; Schwarz U; Törnig J; Matthias S; Orth SR; Mall G; Ritz E
Am J Kidney Dis; 1997 Sep; 30(3):382-8. PubMed ID: 9292567
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
van der Meer P; Lipsic E; Henning RH; Boddeus K; van der Velden J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
J Am Coll Cardiol; 2005 Jul; 46(1):125-33. PubMed ID: 15992646
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
[TBL] [Abstract][Full Text] [Related]
7. Myocyte/capillary mismatch in the heart of uremic patients.
Amann K; Breitbach M; Ritz E; Mall G
J Am Soc Nephrol; 1998 Jun; 9(6):1018-22. PubMed ID: 9621284
[TBL] [Abstract][Full Text] [Related]
8. The impact of early normalization of haematocrit by erythropoietin on renal damage in the remnant kidney model.
Bellizzi V; Sabbatini M; Fuiano G; Sansone G; Magri P; Uccello F; Andreucci M; De Nicola L; Cianciaruso B
Nephrol Dial Transplant; 1998 Sep; 13(9):2210-5. PubMed ID: 9761499
[TBL] [Abstract][Full Text] [Related]
9. Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit.
Lipsic E; Westenbrink BD; van der Meer P; van der Harst P; Voors AA; van Veldhuisen DJ; Schoemaker RG; van Gilst WH
Eur J Heart Fail; 2008 Jan; 10(1):22-9. PubMed ID: 18077209
[TBL] [Abstract][Full Text] [Related]
10. Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats.
Koleganova N; Piecha G; Ritz E; Gross ML
Nephrol Dial Transplant; 2009 Mar; 24(3):778-87. PubMed ID: 18829613
[TBL] [Abstract][Full Text] [Related]
11. Sympathetic blockade prevents the decrease in cardiac VEGF expression and capillary supply in experimental renal failure.
Amann K; Odoni G; Benz K; Campean V; Jacobi J; Hilgers KF; Hartner A; Veelken R; Orth SR
Am J Physiol Renal Physiol; 2011 Jan; 300(1):F105-12. PubMed ID: 20962116
[TBL] [Abstract][Full Text] [Related]
12. Endothelin A receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animals.
Amann K; Münter K; Wessels S; Wagner J; Balajew V; Hergenröder S; Mall G; Ritz E
J Am Soc Nephrol; 2000 Sep; 11(9):1702-1711. PubMed ID: 10966495
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant human erythropoietin on blood pressure and renal function in SHR with chronic renal failure.
Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Sato T; Abe K
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S165-6. PubMed ID: 9072339
[TBL] [Abstract][Full Text] [Related]
14. Functional mechanisms of myocardial microcirculation in left ventricular hypertrophy: a hypothetical model of capillary remodeling post myocardial infarction.
Waller C; Hiller KH; Pfaff D; Gattenlöhner S; Ertl G; Bauer WR
Microvasc Res; 2008 Jan; 75(1):104-11. PubMed ID: 17540413
[TBL] [Abstract][Full Text] [Related]
15. Defective calcium signalling in uraemic platelets and its amelioration with long-term erythropoietin therapy.
Zhou XJ; Vaziri ND
Nephrol Dial Transplant; 2002 Jun; 17(6):992-7. PubMed ID: 12032187
[TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure.
Vaziri ND; Zhou XJ; Naqvi F; Smith J; Oveisi F; Wang ZQ; Purdy RE
Am J Physiol; 1996 Jul; 271(1 Pt 1):E113-22. PubMed ID: 8760088
[TBL] [Abstract][Full Text] [Related]
17. Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension.
Buzello M; Boehm C; Orth S; Fischer B; Ehmke H; Ritz E; Mall G; Amann K
Virchows Arch; 2003 Apr; 442(4):364-71. PubMed ID: 12684765
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
Westenbrink BD; Oeseburg H; Kleijn L; van der Harst P; Belonje AM; Voors AA; Schoemaker RG; de Boer RA; van Veldhuisen DJ; van Gilst WH
Cardiovasc Drugs Ther; 2008 Aug; 22(4):265-74. PubMed ID: 18327705
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin Administration Promotes Expression of VEGF in Renal Ischemic–Reperfusion Injury in Rat Model.
Kongkham S; Sriwong S; Tasanarong A
J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S246-55. PubMed ID: 29927177
[TBL] [Abstract][Full Text] [Related]
20. Nonhypotensive dose of beta-adrenergic blocker ameliorates capillary deficits in the hearts of rats with moderate renal failure.
Amann K; Hofstetter J; Câmpean V; Koch A; Gross ML; Veelken R; Ritz E
Virchows Arch; 2006 Aug; 449(2):207-14. PubMed ID: 16691425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
